Skip to main content
. 2019 Oct 11;3(12):2295–2304. doi: 10.1210/js.2019-00305

Figure 1.

Figure 1.

Tumor response in six patients with ACC using Response Evaluation Criteria in Solid Tumours 1.1 criteria on pembrolizumab plus mitotane regiment. Arrows denote patients that currently remain on pembrolizumab. *, Denotes two patients who were able to undergo additional localized therapy and presently have no evidence of disease.